| Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of … AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ... The Lancet 393 (10189), 2428-2438, 2019 | 1021 | 2019 |
| Maraviroc for previously treated patients with R5 HIV-1 infection RM Gulick, J Lalezari, J Goodrich, N Clumeck, E DeJesus, A Horban, ... New England Journal of Medicine 359 (14), 1429-1441, 2008 | 907 | 2008 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 712 | 2021 |
| Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 … P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ... The Lancet 393 (10167), 143-155, 2019 | 398 | 2019 |
| Bloodstream infections in critically ill patients with COVID‐19 DR Giacobbe, D Battaglini, L Ball, I Brunetti, B Bruzzone, G Codda, ... European journal of clinical investigation 50 (10), e13319, 2020 | 269 | 2020 |
| Whole-genome sequencing reveals host factors underlying critical COVID-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature 607 (7917), 97-103, 2022 | 220 | 2022 |
| Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ... The Journal of infectious diseases 211 (2), 178-186, 2015 | 218 | 2015 |
| The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring G Gatti, A Di Biagio, R Casazza, C De Pascalis, M Bassetti, M Cruciani, ... Aids 13 (15), 2083-2089, 1999 | 204 | 1999 |
| Cardiovascular risk and dyslipidemia among persons living with HIV: a review P Maggi, A Di Biagio, S Rusconi, S Cicalini, M D’Abbraccio, G d’Ettorre, ... BMC infectious diseases 17, 1-17, 2017 | 165 | 2017 |
| Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 … A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ... Journal of antimicrobial chemotherapy 70 (3), 930-940, 2015 | 142 | 2015 |
| Linezolid in the treatment of Gram-positive prosthetic joint infections M Bassetti, F Vitale, G Melica, E Righi, A Di Biagio, L Molfetta, F Pipino, ... Journal of Antimicrobial Chemotherapy 55 (3), 387-390, 2005 | 141 | 2005 |
| Tocilizumab and steroid treatment in patients with COVID-19 pneumonia M Mikulska, LA Nicolini, A Signori, A Di Biagio, C Sepulcri, C Russo, ... Plos one 15 (8), e0237831, 2020 | 127 | 2020 |
| Incidence and prognosis of ventilator-associated pneumonia in critically ill patients with COVID-19: a multicenter study DR Giacobbe, D Battaglini, EM Enrile, C Dentone, A Vena, C Robba, ... Journal of clinical medicine 10 (4), 555, 2021 | 123 | 2021 |
| Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy A Vena, DR Giacobbe, A Di Biagio, M Mikulska, L Taramasso, A De Maria, ... Clinical Microbiology and Infection 26 (11), 1537-1544, 2020 | 122 | 2020 |
| Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies VC Di Maio, V Cento, I Lenci, M Aragri, P Rossi, S Barbaliscia, M Melis, ... Liver international 37 (4), 514-528, 2017 | 99 | 2017 |
| Weight gain: a possible side effect of all antiretrovirals L Taramasso, E Ricci, B Menzaghi, G Orofino, S Passerini, G Madeddu, ... Open forum infectious diseases 4 (4), ofx239, 2017 | 99 | 2017 |
| Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study GV De Socio, E Ricci, P Maggi, G Parruti, G Pucci, A Di Biagio, L Calza, ... American journal of hypertension 27 (2), 222-228, 2014 | 90 | 2014 |
| Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe A De Luca, D Dunn, M Zazzi, R Camacho, C Torti, I Fanti, R Kaiser, ... The Journal of infectious diseases 207 (8), 1216-1220, 2013 | 90 | 2013 |
| The longest persistence of viable SARS-CoV-2 with recurrence of viremia and relapsing symptomatic COVID-19 in an immunocompromised patient—a case study C Sepulcri, C Dentone, M Mikulska, B Bruzzone, A Lai, D Fenoglio, ... Open forum infectious diseases 8 (11), ofab217, 2021 | 89 | 2021 |
| Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation F Marras, E Nicco, F Bozzano, A Di Biagio, C Dentone, E Pontali, S Boni, ... Proceedings of the National Academy of Sciences 110 (29), 11970-11975, 2013 | 84 | 2013 |
Matteo BassettiChair Infectious Diseases Clinic, University of Genoa and San Martino HospitalBestätigte E-Mail-Adresse bei unige.it
